Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-12.82%
operating margin TTM
-14.03%
revenue TTM
2.73 Million
revenue per share TTM
1.01$
valuation ratios | |
|---|---|
| pe ratio | -0.58 |
| peg ratio | -0.02 |
| price to book ratio | 0.10 |
| price to sales ratio | 0.16 |
| enterprise value multiple | -4.20 |
| price fair value | 0.10 |
profitability ratios | |
|---|---|
| gross profit margin | 30.37% |
| operating profit margin | -14.03% |
| pretax profit margin | -12.48% |
| net profit margin | -12.82% |
| return on assets | -14.06% |
| return on equity | -17.88% |
| return on capital employed | -18.11% |
liquidity ratio | |
|---|---|
| current ratio | 5.74 |
| quick ratio | 3.57 |
| cash ratio | 2.70 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 156.19 |
| operating cycle | 191.83 |
| days of payables outstanding | 66.12 |
| cash conversion cycle | 125.71 |
| receivables turnover | 10.24 |
| payables turnover | 5.52 |
| inventory turnover | 2.34 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.02 |
| interest coverage | -58.12 |
| cash flow to debt ratio | -21.23 |
cash flow ratios | |
|---|---|
| free cash flow per share | -10.97 |
| cash per share | 9.63 |
| operating cash flow per share | -9.32 |
| free cash flow operating cash flow ratio | 1.18 |
| cash flow coverage ratios | -21.23 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -5.65 |
Frequently Asked Questions
When was the last time Sunshine Biopharma, Inc. (NASDAQ:SBFM) reported earnings?
Sunshine Biopharma, Inc. (SBFM) published its most recent earnings results on 05-11-2024.
What is Sunshine Biopharma, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Sunshine Biopharma, Inc. (NASDAQ:SBFM)'s trailing twelve months ROE is -17.88%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Sunshine Biopharma, Inc. (SBFM) currently has a ROA of -14.06%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did SBFM's net profit margin stand at?
SBFM reported a profit margin of -12.82% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is SBFM's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.74 in the most recent quarter. The quick ratio stood at 3.57, with a Debt/Eq ratio of 0.02.